Education
About Us
Working with TipRanks
Follow Us
Hepion Pharmaceuticals (HEPA)
OTHER OTC:HEPA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -19.35M | $ -48.45M | $ -45.49M | $ -30.40M | $ -20.15M |
| EBITDA | $ -14.88M | $ -49.26M | $ -45.00M | $ -32.63M | $ -20.11M |
| Net Income | $ -13.19M | $ -48.93M | $ -42.20M | $ -32.72M | $ -20.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 406.41K | $ 14.79M | $ 51.19M | $ 91.35M | $ 40.73M |
| Total Assets | $ 1.61M | $ 18.09M | $ 60.24M | $ 103.55M | $ 48.65M |
| Total Debt | $ 2.90M | $ 209.02K | $ 53.61K | $ 316.99K | $ 752.17K |
| Net Debt | $ 2.49M | $ -14.58M | $ -51.14M | $ -91.03M | $ -39.97M |
| Total Liabilities | $ 3.48M | $ 10.81M | $ 10.39M | $ 10.56M | $ 8.12M |
| Stockholders' Equity | $ -1.86M | $ 7.28M | $ 49.86M | $ 93.00M | $ 40.52M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.22M | $ -40.90M | $ -34.98M | $ -31.35M | $ -16.25M |
| Operating Cash Flow | $ -18.22M | $ -40.89M | $ -34.96M | $ -31.22M | $ -16.17M |
| Investing Cash Flow | $ -600.00K | $ -14.30K | $ -14.07K | $ -130.41K | $ -85.79K |
| Financing Cash Flow | $ 4.35M | $ 4.49M | $ -5.14M | $ 81.98M | $ 43.05M |
Hepion Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.